基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 钆双胺 钆双胺
  • 钆双胺

钆双胺

Gadodiamide
131410-48-5
陕西 更新日期:2019-12-15

XI’AN WANLONG PHARMACEUTICAL CO.,LTD

非会员
联系人:raffia chou
电话:029-81881044拨打
手机:13259794374 拨打
邮箱:raffiachou@hotmail.com

产品详情:

中文名称:
钆双胺
英文名称:
Gadodiamide
CAS号:
131410-48-5
产地:
陕西、西安
纯度规格:
≥99%

Analysis Item

Specification

Results

Idencification

A:Infrared absorption Should conforms with the standard spectrum

 

Conforms

B:The maximum absorption at the relevant wavelength specifiied

Conforms

Microbial limits

500cfu/g

20cfu/g

Bacterial endotoxins

<3.5Eu/mg

Conforms

Water content

Between 3.0% and 14.0%

10.00%

Limit of free gadolinium(lll)

Not more than 0.3%(anhydrous basis)

Not finding

LimitoffreeDiethylenetramine pentaaceticaoidbismethylamide

Not more than 0.7%(anhydrous basis)

0.090%

Limit of methylamine

Not more than 0.05%

0.001%

Limit of acetone, ethyl alcohol,isopropyl alcohol

Acetone

Not more than 0.2%

0.00%

Ethyl alcohol

Not more than 0.2%

0.01%

Isopropyl alcohol

Not more than 0.2%

0.05%

Total impurity

Not more than 0.2%

0.06%

Related comounds

Impurity A

Not more than 2.0%

0.10%

Impurity B

Not more than 2.0%

0.15%

Individual Impurity

Not more than 0.2%

0.05%

Total Impurity (except of Impurity A&B)

Not more than 0.5%

0.29%

Content of gadolinium

26.0~29.0%

28.7%

Assay

97.0~103.0%

99.8%

The material complies with the USP32

complies

 
Gadodiamide;API;avtive pharmaceutical ingredients

公司简介

Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements. There are more than 700 employees including over 70 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development. We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most

成立日期 (29年)
注册资本 7500.000000万
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂
主营行业 医药中间体,原料药

钆双胺相关厂家报价 更多

  • 钆双胺
  • 钆双胺
  • 湖北威德利化学科技有限公司 VIP
  • 2024-04-24
  • ¥4800
  • 钆双铵
  • 钆双铵
  • 武汉鼎信通药业有限公司 VIP
  • 2024-04-24
  • 询价
  • 钆双铵
  • 钆双铵
  • 湖北魏氏化学试剂股份有限公司 VIP
  • 2024-04-24
  • 询价
  • 钆双铵
  • 钆双铵
  • 江西瑞威尔生物科技有限公司 VIP
  • 2024-04-24
  • 询价
  • 钆双胺
  • 钆双胺
  • 武汉鼎信通药业有限公司 VIP
  • 2024-04-24
  • ¥300
  • 钆双铵
  • 钆双铵
  • 湖北威德利化学试剂有限公司 VIP
  • 2024-04-24
  • 询价
内容声明
拨打电话 立即询价